Trial Profile
Open trial of lamotrigine monotherapy in pediatric bipolar disorder
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Aug 2023
Price :
$35
*
At a glance
- Drugs Lamotrigine (Primary)
- Indications Bipolar disorders
- Focus Therapeutic Use
- 29 Jul 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 24 Mar 2009 GlaxoSmithKline added as trial sponsor as reported by ClinicalTrials.gov.
- 24 Mar 2009 Additional trial investigator identified as reported by ClinicalTrials.gov.